Oppenheimer & Co’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-244
Closed -$4K 1540
2022
Q1
$4K Buy
+244
New +$4K ﹤0.01% 1463
2021
Q4
Sell
-383
Closed -$14K 1574
2021
Q3
$14K Sell
383
-382
-50% -$14K ﹤0.01% 1482
2021
Q2
$46K Sell
765
-20
-3% -$1.2K ﹤0.01% 1489
2021
Q1
$53K Sell
785
-500
-39% -$33.8K ﹤0.01% 1418
2020
Q4
$77K Buy
1,285
+58
+5% +$3.48K ﹤0.01% 1317
2020
Q3
$97K Buy
1,227
+248
+25% +$19.6K ﹤0.01% 1232
2020
Q2
$61K Buy
979
+122
+14% +$7.6K ﹤0.01% 1229
2020
Q1
$46K Sell
857
-115
-12% -$6.17K ﹤0.01% 1159
2019
Q4
$118K Sell
972
-126
-11% -$15.3K ﹤0.01% 1235
2019
Q3
$200K Sell
1,098
-873
-44% -$159K 0.01% 1145
2019
Q2
$257K Buy
1,971
+1,110
+129% +$145K 0.01% 1070
2019
Q1
$210K Sell
861
-407
-32% -$99.3K 0.01% 1200
2018
Q4
$242K Sell
1,268
-27
-2% -$5.15K 0.01% 1034
2018
Q3
$426K Buy
1,295
+118
+10% +$38.8K 0.01% 922
2018
Q2
$366K Sell
1,177
-206
-15% -$64.1K 0.01% 987
2018
Q1
$337K Sell
1,383
-152
-10% -$37K 0.01% 1002
2017
Q4
$463K Buy
1,535
+49
+3% +$14.8K 0.01% 889
2017
Q3
$393K Buy
1,486
+52
+4% +$13.8K 0.01% 938
2017
Q2
$378K Buy
1,434
+605
+73% +$159K 0.01% 934
2017
Q1
$298K Buy
829
+403
+95% +$145K 0.01% 1002
2016
Q4
$123K Buy
+426
New +$123K ﹤0.01% 1219